The Medicines Company (NASDAQ:MDCO)

HardnoseDotCom (73.70) Submitted: 4/25/2011 1:35:10 PM : Start Price: $16.17 MDCO Score: +27.77

low PEG, strong price uptrend

medsmall (< 20) Submitted: 4/5/2011 9:32:19 AM : Start Price: $16.31 MDCO Score: +26.24

Price/earnings of 8.28, market cap of 866.36, debt/equity of zero, Return on Invested Capital (TTM) of 35.00, based in New Jersey, United States, pharma company with focus on critical care patients.

HP2006 (92.12) Submitted: 4/1/2011 7:50:16 PM : Start Price: $16.40 MDCO Score: +25.83

screen

SnowBawl (< 20) Submitted: 3/23/2011 8:32:07 AM : Start Price: $16.11 MDCO Score: +24.59

Yahoo small cap value and growth

ruinas (< 20) Submitted: 10/11/2010 11:16:44 AM : Start Price: $13.55 MDCO Score: +37.95

Improving profits in current environment plus recent FDA approval of new product.

Magnet0 (89.30) Submitted: 5/13/2009 5:50:39 PM : Start Price: $7.22 MDCO Score: +134.38

quality company, took a fatty nose dive

zzlangerhans (99.26) Submitted: 2/20/2009 1:07:40 PM : Start Price: $12.61 MDCO Score: -15.16

It's not clear to me why Medicines has fallen so far despite a relatively stable financial picture. Angiomax revenues have been increasing and generics will not be available before 2010 at the earliest. That gives Medicines time to grow Cleviprex revenues and develop their pipeline. I'm not really a bull here but this company has the tools to survive and will likely be one to rebound in the short term when the market stabilizes, given no major negative catalysts.

escarzamd (70.03) Submitted: 5/31/2008 2:26:29 PM : Start Price: $18.25 MDCO Score: +14.05

Hearing good things from cardiologists about Angiomax. recent support from journals. Could be a combo w/BMY for cath patients. No debt on board, so if this drug hits.......the stock could go out of the yard.

popsstocs (< 20) Submitted: 9/8/2007 3:39:10 PM : Start Price: $16.47 MDCO Score: +29.46

I have made some good profits off this CO.I guess it makes all that money from selling all those expensive medications,but what ever,It does me good and I played it again,and its already on its way to do ole pops right again.

StocksdatROCK (40.35) Submitted: 9/4/2007 7:53:25 PM : Start Price: $16.81 MDCO Score: +28.00

Has the worlds favorite item and to many customers

almond9090 (37.61) Submitted: 8/17/2007 5:43:16 AM : Start Price: $16.50 MDCO Score: +28.55

Consistent steady growth with well-established product should slightly outperform the market.

aaroger (< 20) Submitted: 7/27/2007 10:45:14 AM : Start Price: $17.21 MDCO Score: +25.10

34

agard43 (30.60) Submitted: 3/22/2007 10:31:33 PM : Start Price: $25.17 MDCO Score: +16.70

TheStreet.com: "There still seems to be a lot of hope built into the stock price. As Morgan Stanley analyst Stephen Herr wrote this week, "if the patent life is not extended, this stock looks broadly overvalued."

naygoo (52.27) Submitted: 12/11/2006 1:50:32 PM : Start Price: $30.96 MDCO Score: +33.52

Shares of the Medicines Co. (NASDAQ:MDCO - News) fell 10 percent on Monday after the U.S. Congress failed to enact a bill that would have helped the company's bid to extend a patent on its flagship drug Angiomax, a blood thinner.